Werbung
Kursziele der Johnson Johnson-Aktie
*Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 4 | 3 | 1 | 108,31 £ | - |
| Bayer | 10 | 1 | 0 | 80,60 € | - |
| Beiersdorf AG | 9 | 3 | 3 | 104,32 € | -1,49% |
| BioNTech (ADRs) | 1 | 6 | 0 | 215,57 $ | - |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 0 | 0 | - | - |
| Douglas | 0 | 0 | 0 | - | - |
| Fresenius Medical Care AG & Co. KGaA (FMC) St. | 2 | 7 | 3 | 36,47 € | +16,97% |
| Fresenius SE & Co. KGaA (St.) | 6 | 6 | 0 | 33,35 € | +23,43% |
| GSK PLC Registered Shs | 2 | 5 | 1 | 15,42 £ | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 3 | 1 | 213,20 € | +20,52% |
| Moderna Inc | 0 | 0 | 0 | - | - |
| MorphoSys | 1 | 3 | 1 | 31,20 € | +98,10% |
| Nestlé SA (Nestle) | 7 | 5 | 1 | 120,15 CHF | +6,33% |
| Novartis AG | 2 | 4 | 4 | 84,70 CHF | - |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 2 | 4 | 0 | 50,00 $ | -1,75% |
| Procter & Gamble Co. | 0 | 1 | 0 | 165,00 $ | +9,57% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 105,33 € | +23,03% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Unilever plc | 5 | 3 | 3 | 41,68 £ | - |
| Valneva | 2 | 0 | 0 | 25,75 € | +284,33% |